Reviewing ANI Pharmaceuticals (NASDAQ:ANIP) and Elixinol Wellness (OTCMKTS:ELLXF)

Elixinol Wellness (OTCMKTS:ELLXF) and ANI Pharmaceuticals (NASDAQ:ANIP) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

Analyst Recommendations

This is a summary of current ratings and price targets for Elixinol Wellness and ANI Pharmaceuticals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elixinol Wellness	0	0	0	0	N/A
ANI Pharmaceuticals	0	1	5	0	2.83

ANI Pharmaceuticals has a consensus target price of $77.00, indicating a potential upside of 29.06%. Given ANI Pharmaceuticals’ higher probable upside, analysts plainly believe ANI Pharmaceuticals is more favorable than Elixinol Wellness.

Profitability

This table compares Elixinol Wellness and ANI Pharmaceuticals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Elixinol Wellness	N/A	N/A	N/A
ANI Pharmaceuticals	5.01%	15.64%	7.63%

Insider and Institutional Ownership

76.1% of ANI Pharmaceuticals shares are owned by institutional investors. 12.7% of ANI Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Elixinol Wellness and ANI Pharmaceuticals”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elixinol Wellness	N/A	N/A	N/A	N/A	N/A
ANI Pharmaceuticals	$538.95 million	2.32	$18.78 million	$1.60	37.29

ANI Pharmaceuticals has higher revenue and earnings than Elixinol Wellness.

Summary

ANI Pharmaceuticals beats Elixinol Wellness on 8 of the 8 factors compared between the two stocks.

About Elixinol Wellness

Elixinol Wellness Limited, through its subsidiaries, engages in the manufacture and distribution of hemp derived nutraceuticals, skincare, and food products in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.

About ANI Pharmaceuticals

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.